Actively Recruiting

Phase Not Applicable
Age: 18Years - 50Years
All Genders
ID06003036

Accelerated Neuromodulation of Prefrontal Circuitry During Clozapine Treatment

Led by Deepak K. Sarpal, M.D. · Updated on 2026-04-13

30

Participants Needed

1

Research Sites

17 weeks

Total Duration

On this page

Sponsors

D

Deepak K. Sarpal, M.D.

Lead Sponsor

N

National Institute of Mental Health (NIMH)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are investigating whether a specific type of repetitive transcranial magnetic stimulation called accelerated intermittent theta burst stimulation (iTBS) can improve brain function in people with schizophrenia or schizoaffective disorder who are being treated with clozapine. This study involves adults aged 18 to 50 years who have been on clozapine for at least four months and have a history of at least two unsuccessful antipsychotic treatments. The goal is to see if iTBS can enhance neurocognition compared to a sham (placebo) treatment. Participants will receive two sessions in a randomized, blinded order: one session of iTBS combined with magnetic resonance imaging (MRI) and one session of sham stimulation combined with MRI. Both interventions involve using a device to deliver the magnetic stimulation. The study measures brain activity and connectivity changes during these sessions to assess the effects of the treatment. During the study, participants will undergo baseline evaluations and MRI scans. Researchers will measure changes in functional brain connectivity within the prefrontal cortex and activation of the working memory network shortly after treatment. Additionally, they will explore changes in brain imaging measures related to clozapine blood levels over one month. Safety, adherence, and cognitive effects will be monitored throughout the study, which is expected to last until July 2026.

CONDITIONS

Brief Title

Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine

Who Can Participate

Age: 18Years - 50Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • A current diagnosis of schizophrenia or schizoaffective disorder based on DSM 5 criteria
  • Age between 18 and 50 years
  • At least 4 months of treatment with clozapine
  • History of at least 2 failed antipsychotic trials
  • Competent and willing to provide informed consent
  • Clinically optimized clozapine dosage, unchanged for at least 1 month, with a minimum of 150 mg/day
Not Eligible

You will not qualify if you...

  • Serious neurological or medical conditions or treatments affecting the brain
  • Significant risk of suicidal or homicidal behavior
  • Cognitive or language difficulties preventing informed consent
  • Pregnancy or postpartum status less than 6 weeks after delivery or miscarriage
  • History of electroconvulsive therapy
  • Contraindications for MRI, such as having a pacemaker
  • Moderate or severe substance use disorder confirmed by DSM 5, including alcohol use disorder
  • Seizure disorder or prior seizures while on clozapine
  • Current use of both bupropion and clozapine
  • Previous problems with intermittent theta burst or transcranial magnetic stimulation treatments

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - Short periods for each intervention with washout in between

Participants receive accelerated transcranial magnetic stimulation or sham stimulation in a crossover design.

Multiple visits for receiving both active and sham stimulation sessions

Monitoring

Duration - Up to 1 month after interventions

Participants are observed to evaluate changes in brain function and treatment effects after stimulation sessions.

Follow-up visits including functional MRI assessments

Trial Site Locations

Total: 1 location

1

UPMC Western Psychiatric Hospital/University of Pittsburgh

Pittsburgh, Pennsylvania, United States, 15213

Actively Recruiting

Loading map...

Research Team

T

Tori Blazinski

D

Deepak Sarpal

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

BASIC_SCIENCE

Number of Arms

2

Similar Trials

Effects of Multi-Session 40 Hz Visual Stimulation on Neurona...

Negative Symptoms in Schizophrenia

Actively Recruiting

1 location

A Randomized, Open-label, Multicenter, Two-formulation, Mult...

Schizophrenia

Actively Recruiting

1 location

A Multi-Center, Randomized, Double-Blind, Parallel-Design St...

Schizophrenia

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here